drugset / Trial / NCT02266030

Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM

NCT02266030

Phase 3 Completed 100 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective interventional study to assess the effect of cilostazol compared with aspirin in Korean T2DM patients with atherosclerosis.

Timeline

Start
2011-02
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 100 mg
Subject Cilostazol Small molecule 100 mg
Subject Cilostazol Small molecule 200 mg